Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 33 results for "fresenius kabi oncology"

Finance Ministry clears 20 FDI proposals worth Rs 988 crore
IndiaTV News


The Ministry of Finance (MoF), Government of India , has cleared 20 foreign direct investment (FDI) proposals, including six in the pharmaceutical sector, envisaging a total inflow of Rs988.3 crore after approval by the Foreign Investment ... 4 Traders, 3 days ago
Govt approves 20 FDI proposals worth Rs 988.3 cr Hindu Business Line, 1 week ago
FDI Proposals worth Rs 988 cr Approved New Indian Express, 6 days ago

Equitas Holdings among 20 FDI proposals worth ₹988 cr cleared

The Government approved 20 Foreign Direct Investment proposals worth ₹988.3 crore and rejected five including Sistema Shyam Teleservices bid to raise foreign stake holding in the company to 100 per cent. The decisions have been taken based on a ...
 Hindu Business Line6 days ago

Government approves Twenty (20) Proposals of Foreign Direct Investment amounting to Rs 988.3 Crore

Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its meeting held on September 16, 2014, the Government has approved twenty (20) proposals of Foreign Direct Investment amounting to Rs. 988.3 crore approximately. Details ...
 Noodls1 week ago Ministry of Finance of Republic of India : Government approves Twenty (20) Proposals of Foreign Direct Investment amounting to Rs 988.3 Crore  4 Traders1 week ago

PFIZER : Fresenius Kabi Oncology Withdraws Patent Pleas Against Pfizer Over Cancer Drugs

Crizotinib is branded as Xalkori, while Axitinib as Inlyta by Pfizer . Fresenius Kabi has informed its decision to withdraw four petitions against patent of Crizotinib and one against Axitinib with the Intellectual Property Appellate Board (IPAB) ...
 4 Traders1 month ago Pfizer : FRESENIUS KABI WITHDRAWS PATENT PLEAS AGAINST PFIZER  4 Traders1 month ago Fresenius Kabi withdraws patent pleas against Pfizer  Financial Express1 month ago
Business Standard

Fresenius Kabi withdraws petitions against Pfizer cancer patents

Cancer drug major Fresenius Kabi Oncology Ltd, the Indian arm of Germany-based Fresenius Kabi, has withdrew revocation petitions against cancer drug patents owned by Pfizer and its subsidiaries as the former has "lost business interest" in the molecules. The ...
 Business Standard1 month ago

Human medicines European public assessment report (EPAR): Docetaxel Kabi, docetaxel, Revision: 5, Authorised

This is a summary of the European public assessment report (EPAR) for Docetaxel Kabi. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing ...
 European Medicines Agency1 month ago

Regulatory experts push for pharma cos to strengthen data integrity

Regulatory experts stressed that the Indian pharma cos should put special focus on following all the data integrity requirements to avoid crackdown by regulatory agencies. This warning comes in the wake of growing incidence of issuance of letters by ...
 PharmaBiz1 month ago

Pfizer inks COPD promo deal with Novartis in U.K.; Roche chair says no big mergers;

@FiercePharma: Tops on FPMarketing Weds: Can Sanofi/Regeneron's new data one-up Amgen in megablockbuster PCSK9 field? Article | Follow @FiercePharma @EricPFierce: Agents in EU seize €10M worth of counterfeit drugs, as well as cash and luxury ...
 FiercePharma1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less